A lightweight emollient that mimics a lipid skin already makes; a carrier and softener rather than an active.
More on this ingredient: read the guide.
Read the neutral reference entry →No interaction to manage. Squalane is oil-soluble and chemically unreactive, so it sits alongside an L-ascorbic acid serum without affecting its pH or stability. Apply the watery serum first, the oil after.
Squalane is an inert emollient, not an active, so it does not compete with a retinoid. It is one of the standard ways to buffer one: applied before or after, it softens the early dryness without switching the retinoid off.
A common and uncomplicated pairing — a humectant-and-emollient step over a niacinamide serum. Squalane is non-comedogenic (0–1), so it suits oily and blemish-prone skin better than heavier oils.
These do different jobs and work best together: hyaluronic acid draws water in, squalane slows its escape. Hyaluronic acid on damp skin first, squalane on top — the reverse order leaves the humectant with less to hold.
Both are barrier-support lipids and they are routinely formulated together. Nothing to separate; this is the moisturising end of a routine rather than a combination to manage.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.
This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.